BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 33117363)

  • 1. A Mucosal Adenovirus Prime/Systemic Envelope Boost Vaccine Regimen Elicits Responses in Cervicovaginal and Alveolar Macrophages of Rhesus Macaques Associated With Delayed SIV Acquisition and B Cell Help.
    Hunegnaw R; Helmold Hait S; Enyindah-Asonye G; Rahman MA; Ko EJ; Hogge CJ; Hoang T; Robert-Guroff M
    Front Immunol; 2020; 11():571804. PubMed ID: 33117363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination Adenovirus and Protein Vaccines Prevent Infection or Reduce Viral Burden after Heterologous Clade C Simian-Human Immunodeficiency Virus Mucosal Challenge.
    Malherbe DC; Mendy J; Vang L; Barnette PT; Reed J; Lakhashe SK; Owuor J; Gach JS; Legasse AW; Axthelm MK; LaBranche CC; Montefiori D; Forthal DN; Park B; Wilson JM; McLinden JH; Xiang J; Stapleton JT; Sacha JB; Haynes BF; Liao HX; Ruprecht RM; Smith J; Gurwith M; Haigwood NL; Alexander J
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early T Follicular Helper Cell Responses and Germinal Center Reactions Are Associated with Viremia Control in Immunized Rhesus Macaques.
    Helmold Hait S; Vargas-Inchaustegui DA; Musich T; Mohanram V; Tuero I; Venzon DJ; Bear J; Rosati M; Vaccari M; Franchini G; Felber BK; Pavlakis GN; Robert-Guroff M
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30463978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted lymph-node immunization with whole inactivated simian immunodeficiency virus (SIV) or envelope and core subunit antigen vaccines does not reliably protect rhesus macaques from vaginal challenge with SIVmac251.
    Lü X; Kiyono H; Lu D; Kawabata S; Torten J; Srinivasan S; Dailey PJ; McGhee JR; Lehner T; Miller CJ
    AIDS; 1998 Jan; 12(1):1-10. PubMed ID: 9456249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Complement-Mediated Lysis of Simian Immunodeficiency Virus (SIV) and SIV-Infected Cells Reveals Sex Differences in Vaccine-Induced Immune Responses in Rhesus Macaques.
    Miller-Novak LK; Das J; Musich TA; Demberg T; Weiner JA; Venzon DJ; Mohanram V; Vargas-Inchaustegui DA; Tuero I; Ackerman ME; Alter G; Robert-Guroff M
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replicating Adenovirus-SIV Immunization of Rhesus Macaques Induces Mucosal Dendritic Cell Activation and Function Leading to Rectal Immune Responses.
    Ko EJ; Helmold Hait S; Enyindah-Asonye G; Rahman MA; Hoang T; Robert-Guroff M
    Front Immunol; 2019; 10():779. PubMed ID: 31031768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Prime/Boost Vaccine Regimen Alters the Rectal Microbiome and Impacts Immune Responses and Viremia Control Post-Simian Immunodeficiency Virus Infection in Male and Female Rhesus Macaques.
    Musich T; Thovarai V; Venzon DJ; Mohanram V; Tuero I; Miller-Novak LK; Helmold Hait S; Rahman MA; Hunegnaw R; Huiting E; Yuan W; O'hUigin C; Hoang T; Sui Y; LaBranche C; Montefiori D; Bear J; Rosati M; Bissa M; Berzofsky JA; Pavlakis GN; Felber BK; Franchini G; Robert-Guroff M
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32967951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with slow disease progression in macaques immunized with an adenovirus-simian immunodeficiency virus (SIV) envelope priming-gp120 boosting regimen and challenged vaginally with SIVmac251.
    Buge SL; Murty L; Arora K; Kalyanaraman VS; Markham PD; Richardson ES; Aldrich K; Patterson LJ; Miller CJ; Cheng SM; Robert-Guroff M
    J Virol; 1999 Sep; 73(9):7430-40. PubMed ID: 10438833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An adenovirus-simian immunodeficiency virus env vaccine elicits humoral, cellular, and mucosal immune responses in rhesus macaques and decreases viral burden following vaginal challenge.
    Buge SL; Richardson E; Alipanah S; Markham P; Cheng S; Kalyan N; Miller CJ; Lubeck M; Udem S; Eldridge J; Robert-Guroff M
    J Virol; 1997 Nov; 71(11):8531-41. PubMed ID: 9343211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T
    Helmold Hait S; Hogge CJ; Rahman MA; Hunegnaw R; Mushtaq Z; Hoang T; Robert-Guroff M
    Front Immunol; 2020; 11():608003. PubMed ID: 33584682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved protection of rhesus macaques against intrarectal simian immunodeficiency virus SIV(mac251) challenge by a replication-competent Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinant priming/gp120 boosting regimen.
    Zhao J; Pinczewski J; Gómez-Román VR; Venzon D; Kalyanaraman VS; Markham PD; Aldrich K; Moake M; Montefiori DC; Lou Y; Pavlakis GN; Robert-Guroff M
    J Virol; 2003 Aug; 77(15):8354-65. PubMed ID: 12857905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An SAMT-247 Microbicide Provides Potent Protection against Intravaginal Simian Immunodeficiency Virus Infection of Rhesus Macaques, whereas an Added Vaccine Component Elicits Mixed Outcomes.
    Helmold Hait S; Hogge CJ; Rahman MA; Ko EJ; Hunegnaw R; Mushtaq Z; Enyindah-Asonye G; Hoang T; Miller Jenkins LM; Appella E; Appella DH; Robert-Guroff M
    J Immunol; 2020 Jun; 204(12):3315-3328. PubMed ID: 32393514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal B Cells Are Associated with Delayed SIV Acquisition in Vaccinated Female but Not Male Rhesus Macaques Following SIVmac251 Rectal Challenge.
    Tuero I; Mohanram V; Musich T; Miller L; Vargas-Inchaustegui DA; Demberg T; Venzon D; Kalisz I; Kalyanaraman VS; Pal R; Ferrari MG; LaBranche C; Montefiori DC; Rao M; Vaccari M; Franchini G; Barnett SW; Robert-Guroff M
    PLoS Pathog; 2015 Aug; 11(8):e1005101. PubMed ID: 26267144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced immunity and protective efficacy against SIVmac251 intrarectal challenge following ad-SIV priming by multiple mucosal routes and gp120 boosting in MPL-SE.
    Pinczewski J; Zhao J; Malkevitch N; Patterson LJ; Aldrich K; Alvord WG; Robert-Guroff M
    Viral Immunol; 2005; 18(1):236-43. PubMed ID: 15802969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Envelope-modified single-cycle simian immunodeficiency virus selectively enhances antibody responses and partially protects against repeated, low-dose vaginal challenge.
    Alpert MD; Rahmberg AR; Neidermyer W; Ng SK; Carville A; Camp JV; Wilson RL; Piatak M; Mansfield KG; Li W; Miller CJ; Lifson JD; Kozlowski PA; Evans DT
    J Virol; 2010 Oct; 84(20):10748-64. PubMed ID: 20702641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine-modified NF-kB and GR signaling in cervicovaginal epithelium correlates with protection.
    Shang L; Smith AJ; Reilly CS; Duan L; Perkey KE; Wietgrefe S; Zupancic M; Southern PJ; Johnson RP; Carlis JV; Haase AT
    Mucosal Immunol; 2018 Mar; 11(2):512-522. PubMed ID: 28792003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alveolar Macrophage Dysfunction and Increased PD-1 Expression During Chronic SIV Infection of Rhesus Macaques.
    Hunegnaw R; Mushtaq Z; Enyindah-Asonye G; Hoang T; Robert-Guroff M
    Front Immunol; 2019; 10():1537. PubMed ID: 31333668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent HIV-1-Directed Immune Responses Generated by Systemic and Mucosal Immunization with Replicating Single-Cycle Adenoviruses in Rhesus Macaques.
    Matchett WE; Anguiano-Zarate SS; Nehete PN; Shelton K; Nehete BP; Yang G; Dorta-Estremera S; Barnette P; Xiao P; Byrareddy SN; Villinger F; Hessell AJ; Haigwood NL; Sastry KJ; Barry MA
    J Virol; 2019 May; 93(10):. PubMed ID: 30842321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vector Order Determines Protection against Pathogenic Simian Immunodeficiency Virus Infection in a Triple-Component Vaccine by Balancing CD4
    Sauermann U; Radaelli A; Stolte-Leeb N; Raue K; Bissa M; Zanotto C; Krawczak M; Tenbusch M; Überla K; Keele BF; De Giuli Morghen C; Sopper S; Stahl-Hennig C
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28904195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose penile SIVmac251 exposure of rhesus macaques infected with adenovirus type 5 (Ad5) and then immunized with a replication-defective Ad5-based SIV gag/pol/nef vaccine recapitulates the results of the phase IIb step trial of a similar HIV-1 vaccine.
    Qureshi H; Ma ZM; Huang Y; Hodge G; Thomas MA; DiPasquale J; DeSilva V; Fritts L; Bett AJ; Casimiro DR; Shiver JW; Robert-Guroff M; Robertson MN; McChesney MB; Gilbert PB; Miller CJ
    J Virol; 2012 Feb; 86(4):2239-50. PubMed ID: 22156519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.